Biotech Values

[daved]

pgs .05 is arbitrary and is 95% chance of non random results. For pain relief and other broad applications for which there are many existing treatments perhaps that standard should be raised to .04 or .03. For orphan indications one could argue that the bar should be lowered to .06 or so.

Nowhere did I see David suggest that the bar should be lowered in most cases.


Regards,

Dave